2025
A Shoulder to CROI On
HANC Deputy Director shares an emotional experience at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI). Read their compelling journey with research and community over 4 days in San Francisco, CA.
HANC Launches the U.S. HIV Research Desert Map
This interactive map conceived by the Office of HIV/AIDS Network Coordination (HANC) in partnership with Evidence2Practice (E2P), highlights geographic coverage and gaps in the HIV/AIDS clinical research infrastructure in the United States (U.S.).
The map features the distribution of the U.S.-based clinical research sites conducting studies through the National Institutes of Health (NIH) HIV/AIDS clinical trials networks, the Centers for AIDS Research (CFAR) sites, and the Ending the HIV Epidemic in the U.S. (EHE) priority jurisdictions, in geographic relation to Historically Black Colleges and Universities (HBCUs) and Tribal Colleges and Universities (TCUs).
2024
HANC goes to Austin for Evidence 2 Practice (E2P) at the University of Texas
HANC Director and E2P Co-found Russell Campbell and HANC Project Coordinator Murph Fuentes go South for the University of Texas School of Pharmacy E2P workshop. See the passion and commitment of these future pharmacists and the role they can assume towards the advancement within the HIV care continuum and beyond. Because at the University of Texas, "What Starts Here Changes the World."
NIAID Responds to Community Input on the Future of HIV Research
NIAID Talks Back on Recompetition Goals
This year, the National Institute of Allergy and Infectious Diseases (NIAID) has been soliciting input on the future of its major HIV research networks and clinical trials units. Many individuals and organizations have submitted their priorities for the future of HIV research, and NIAID has now posted responses to these priorities on their website:
The solicitation for input remains open; you can submit questions and comments by emailing NextNIAIDHIVNetworks@mail.nih.gov. More information is available here.
HANC Goes to Peru for HIV R4P
HIV R4P 2024
HANC Deputy Director Brian Minalga attends HIV R4P 2024: the only global scientific conference focused exclusively on the challenging and fast-growing field of HIV prevention research. This conference fosters interdisciplinary knowledge exchange on HIV vaccines, microbicides, PrEP, treatment as prevention and biomedical interventions, as well as their social and behavioural implications. Held in Lima, Peru, it was a worldwind of compelling science along with old and new amigos.
HANC Represents at the 2024 IMPAACT Annual Network Meeting
IMPAACT Annual Network Meeting 2024
HANC Director Russell Cambell and Project Coordinators Murph Fuentes and Gabriella Olague take on the 2024 IMPAACT Annual Network Meeting in Arlington, VA.
Director Russell Campbell led compelling ICAB sessions and HANC spoke with Network Chair Dr. Sharon Nachman on the future network priorites. Learn more about HANC's week absorbing the infant, maternal, pediatric, and adolescent science in the context of HIV at the link.
HANC Hosts Community Partners Face 2 Face Meeting
Community Partners Face 2 Face Meeting 2024
Led by Project Manager Greg Davis, HANC Director Russell Campbell and Project Coordinator Murph Fuentes join the first Community Partners in-person meeting since COVID!
Two packed days filled with a new logo reveal, a visit from Director of DAIDS Dr. Carl Dieffenbach, and all the passion of this global community fighting for CAB and research site harmony in the name of science. Click below to learn more.
HANC Embraces Southern Joy at USCHA 2024
United States Conference on HIV/AIDS (USCHA) 2024
HANC Director Russell Campbell, Deputy Director Brian Minalga, Legacy Project Manager Cat Banobi, and Project Coordinators Murph Fuentes and Gabriella Olague represent in New Orleans for USCHA 2024.
Click below for a comprehensive recap filled with exclusive interviews from old and new friends, and so much Southern Joy and strength.
Make Your Voice Heard for the Future of HIV Research
NIAID Wants to Hear from You
Currently, the National Institute of Allergy and Infectious Diseases (NIAID) supports four research networks with about 100 research sites as part of its HIV clinical research enterprise. NIAID is currently soliciting feedback to inform its next seven-year funding cycle of HIV research. Please share your input by emailing NextNIAIDHIVNetworks@mail.nih.gov
Miss Molly Moon Takes Munich for AIDS 2024
International AIDS Society (IAS) AIDS 2024
HANC Deputy Director Brian Minalga and Miss Molly Moon represent in Munich for the AIDS 2024 conference.
Click below for a comprehensive recap filled with old and new friends, trans representation in HIV research, some unprescedented results from the PURPOSE 1 Trial and all the glitz Molly can offer.
Network Spotlight
HPTN Network Spotlight: HANC Director Russell Campbell
Russell Campbell, HANC Director, is featured in the Network Member Spotlight of the HPTN July 2024 Newsletter
HANC Takes On the 2024 ACTG and HPTN Annual Network Meetings
2024 Annual ACTG and HPTN Network Meetings
Team HANC comprised of Deputy Director Brian Minalga, Legacy Project Manager Cat Banobi, and Cross-Network Project Manager Kathleen Pescasio took both the ACTG and HPTN 2024 Annual Meetings by storm this June in Washington, DC.
Click below for a recap of the compelling knowledge and networking achieved at each meeting.
Our Words Have Power—NIAID Embraces Respectful, Inclusive, and Person-First Language
NIAID Director Dr. Jeanne Marrazzo & the NIAID HIV Language Guide
NIAID Director Dr. Jeanne Marrazzo, M.D., M.P.H., comments on the new NIAID HIV Langauage Guide and how this powerful tool will inform future HIV research.
An Educational Video Series
What Happens to Lab Samples
HANC invited community representatives from the four NIH-funded HIV/AIDS clinical trials networks to submit their questions about research study specimens. In response, HANC produced a video filmed at the UCSF-Hair Analytical Laboratory.
Watch the full length video and video shorts.
To request downloadable videos, please contact HANC at hancadmin@hanc.info.com.
Updates to DAIDS SCORE Manual
The DAIDS Office of Clinical Site Oversight (OCSO) has revised the following sections of the SCORE Manual:
- Appendix Source Documentation Requirements
- Informed Consent of Participants
- Site Visits
For more information, see the signed memo and summary of changes.
Community & Stakeholder Input to Inform the Future of HIV Research Webinar
HANC invites you to join conversations with Dr. Carl Dieffenbach, Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) about the future of global HIV research.
Dr. Dieffenbach led a robust discussion with topics ranging from structural issues, HIV cure-related research, HIV prevention, aging on ART, funding, the future of bnABs, participant inclusion, and how the Representative Studies Rubric (RSR) addresses questions of representation in terms of age, ethnicity, gender, injection drug use, pregnancy, race, and sex assigned at birth. Watch the full recording for the in-depth conversation.
Stay tuned for future webinars - conversations, with Dr. Carl Dieffenbach.
HANC Takes on the Biomedical HIV Prevention Summit
Team HANC comprised of Russell Campbell, Brian Minalga, Cat Banobi, Gabriella Olague, and Murph Fuentes experienced all BHPS 2024 had to offer. Held over a remarkably sunny two days in Seattle, it was filled with hope and inspiration with a great focus on PrEP initiatives and Native Holistic Innovations. Moving plenaries were rounded out by informative workshops - sure to energize the team.
Read more about the 2024 summit.
Welcoming New HANC Staff
We are delighted to announce that HANC is welcoming two new staff members! Murph Fuentes started on February 20th as the new HANC Project Coordinator. She will assist in the coordination of HANC activities across the Networks. Cat Banobi begins on March 11th as HANC's new Legacy Project Manager, where she will support the efforts of the Legacy Project to improve the participation of underrepresented communities in clinical trials. Please join us in welcoming Murph and Cat!
Learn more about the HANC team.